S&P 500   3,959.73 (-3.16%)
DOW   31,767.35 (-2.72%)
QQQ   295.47 (-3.49%)
AAPL   143.22 (-4.03%)
MSFT   257.79 (-3.38%)
FB   196.13 (-3.20%)
GOOGL   2,267.29 (-2.67%)
AMZN   2,185.07 (-5.30%)
TSLA   721.32 (-5.29%)
NVDA   173.10 (-4.77%)
BABA   88.81 (-3.46%)
NIO   16.12 (-3.07%)
AMD   98.25 (-4.12%)
CGC   5.77 (-2.04%)
MU   71.32 (-4.24%)
T   20.37 (-0.97%)
GE   75.84 (-0.73%)
F   12.99 (-3.99%)
DIS   105.93 (-2.49%)
AMC   13.21 (+2.40%)
PFE   50.64 (-1.36%)
PYPL   78.52 (-1.54%)
NFLX   180.84 (-5.10%)
S&P 500   3,959.73 (-3.16%)
DOW   31,767.35 (-2.72%)
QQQ   295.47 (-3.49%)
AAPL   143.22 (-4.03%)
MSFT   257.79 (-3.38%)
FB   196.13 (-3.20%)
GOOGL   2,267.29 (-2.67%)
AMZN   2,185.07 (-5.30%)
TSLA   721.32 (-5.29%)
NVDA   173.10 (-4.77%)
BABA   88.81 (-3.46%)
NIO   16.12 (-3.07%)
AMD   98.25 (-4.12%)
CGC   5.77 (-2.04%)
MU   71.32 (-4.24%)
T   20.37 (-0.97%)
GE   75.84 (-0.73%)
F   12.99 (-3.99%)
DIS   105.93 (-2.49%)
AMC   13.21 (+2.40%)
PFE   50.64 (-1.36%)
PYPL   78.52 (-1.54%)
NFLX   180.84 (-5.10%)
S&P 500   3,959.73 (-3.16%)
DOW   31,767.35 (-2.72%)
QQQ   295.47 (-3.49%)
AAPL   143.22 (-4.03%)
MSFT   257.79 (-3.38%)
FB   196.13 (-3.20%)
GOOGL   2,267.29 (-2.67%)
AMZN   2,185.07 (-5.30%)
TSLA   721.32 (-5.29%)
NVDA   173.10 (-4.77%)
BABA   88.81 (-3.46%)
NIO   16.12 (-3.07%)
AMD   98.25 (-4.12%)
CGC   5.77 (-2.04%)
MU   71.32 (-4.24%)
T   20.37 (-0.97%)
GE   75.84 (-0.73%)
F   12.99 (-3.99%)
DIS   105.93 (-2.49%)
AMC   13.21 (+2.40%)
PFE   50.64 (-1.36%)
PYPL   78.52 (-1.54%)
NFLX   180.84 (-5.10%)
S&P 500   3,959.73 (-3.16%)
DOW   31,767.35 (-2.72%)
QQQ   295.47 (-3.49%)
AAPL   143.22 (-4.03%)
MSFT   257.79 (-3.38%)
FB   196.13 (-3.20%)
GOOGL   2,267.29 (-2.67%)
AMZN   2,185.07 (-5.30%)
TSLA   721.32 (-5.29%)
NVDA   173.10 (-4.77%)
BABA   88.81 (-3.46%)
NIO   16.12 (-3.07%)
AMD   98.25 (-4.12%)
CGC   5.77 (-2.04%)
MU   71.32 (-4.24%)
T   20.37 (-0.97%)
GE   75.84 (-0.73%)
F   12.99 (-3.99%)
DIS   105.93 (-2.49%)
AMC   13.21 (+2.40%)
PFE   50.64 (-1.36%)
PYPL   78.52 (-1.54%)
NFLX   180.84 (-5.10%)
LON:ETX

e-therapeutics (ETX) Share Forecast, Price & News

GBX 21.40
-1.40 (-6.14%)
(As of 05/18/2022 04:12 PM ET)
Add
Compare
Today's Range
21
23.10
50-Day Range
22.20
27.50
52-Week Range
16.41
49.50
Volume
126,271 shs
Average Volume
394,128 shs
Market Capitalization
£110.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive ETX News and Ratings via Email

Sign-up to receive the latest news and ratings for e-therapeutics and its competitors with MarketBeat's FREE daily newsletter.

e-therapeutics logo

About e-therapeutics

e-Therapeutics plc operates as a drug discovery company in the United Kingdom. The company's Network-Driven Drug Discovery platform perform in silico phenotypic screens to generate sets of small molecules that are enriched in active compounds ensuring high in vitro hit rates in complex phenotypic screens; and Genome-Associated Interaction Networks platform to analyze genome-wide association study data, which identifies disease variants at the genome level to identify potential intervention strategies, therapies, and diagnostics, as well as developing RNAi platform to modulate any gene to harness novel targets identified computationally. It also develops search engine technology. The company was founded in 2001 and is based in Long Hanborough, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
33
Year Founded
N/A

Sales & Book Value

Annual Sales
£757 thousand
Cash Flow
GBX 5.46 per share
Book Value
GBX 6.40 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£110.12 million
Optionable
Not Optionable

Company Calendar

Last Earnings
3/17/2020
Today
5/18/2022

MarketRank

Overall MarketRank

0.80 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













e-therapeutics (LON:ETX) Frequently Asked Questions

How were e-therapeutics' earnings last quarter?

e-therapeutics plc (LON:ETX) issued its quarterly earnings results on Tuesday, March, 17th. The company reported ($0.87) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.90) by $0.03.
View e-therapeutics' earnings history
.

Who are e-therapeutics' key executives?
e-therapeutics' management team includes the following people:
  • Mr. Ahmad Ali Mortazavi, CEO & Director (Age 51, Pay $135.89k)
  • Mr. Michael Anthony Bretherton ACA, B.A., Acting Interim CFO & Director (Age 67, Pay $39k)
  • Mr. Jonny Wray Ph.D., Chief Technology Officer
  • Mr. Alan Whitmore B.Sc., Ph.D., Chief Scientific Officer
  • Ms. Sarah Clare, Director of Fin. & Compliance
  • Ms. Stephanie Maley CIPD, Chief People Officer
  • Dr. Laura Roca-Alonso Ph.D., Chief Bus. Officer
  • Ms. Alison Gallafent, Chief Intellectual Property Officer
What other stocks do shareholders of e-therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other e-therapeutics investors own include Radware (RDWR), Sound Energy (SOU), 4D pharma (DDDD), Chicken Soup for the Soul Entertainment (CSSE), Crescent Point Energy (CPG), Collagen Solutions plc (COS.L) (COS), (BV), BP (BP), Bushveld Minerals (BMN) and Alstom (ALSMY).

What is e-therapeutics' stock symbol?

e-therapeutics trades on the London Stock Exchange (LON) under the ticker symbol "ETX."

How do I buy shares of e-therapeutics?

Shares of ETX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is e-therapeutics' stock price today?

One share of ETX stock can currently be purchased for approximately GBX 21.40.

How much money does e-therapeutics make?

e-therapeutics has a market capitalization of £110.12 million and generates £757 thousand in revenue each year.

How many employees does e-therapeutics have?

e-therapeutics employs 33 workers across the globe.

What is e-therapeutics' official website?

The official website for e-therapeutics is www.etherapeutics.co.uk.

How can I contact e-therapeutics?

e-therapeutics' mailing address is 17 Blenheim Office Park, WITNEY, OX29 8LN, United Kingdom. The company can be reached via phone at +44-1993-880000.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.